Article Details
Retrieved on: 2025-05-08 12:56:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Their lead product candidate, AlloNK, is being evaluated in combination with B-cell targeted monoclonal antibodies in multiple clinical trials ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here